B. Braun Medical acquires Dismed's hand sanitizer and intravenous fluid businesses in South Africa

Utl.: Commitment to growth and local manufacturing for the African
healthcare sector =

Melsungen/Johannesburg (ots) - On 30 June 2016, B. Braun Medical, the
South African subsidiary of the German B. Braun Group, completed its
acquisition of Dismed Pharmaceutical (Pty) Ltd and Dismed Criticare
(Pty) Ltd, both out of business rescue.

With over 600 employees in South Africa, B. Braun specialises in the
sales and logistics of medical devices, surgical instruments,
consumables, pharmaceuticals and is one of the country's leading and
fastest growing operators of dialysis clinics. In 2011, B. Braun
Medical established its first local manufacturing site for medical
devices in Knysna, Western Cape.

"The Dismed acquisitions support our mission of being a system
supplier with a well-rounded portfolio of effective medical care
solutions in South Africa", said B. Braun Medical's managing
director, Jens Papperitz. "After resolving operational issues in both
acquired businesses, we will be able to offer our public and private
customers in Southern Africa the same level of excellence they have
come to expect from us based on our other product portfolio we
currently supply to them", added Papperitz.

With a triple digit million Rand spending for purchase price and
subsequent investments into production equipment, B. Braun Medical
ensures the continuing employment of all 120 staff at two
manufacturing facilities in Gauteng.

This investment into the healthcare and manufacturing sector is also
an indication of the confidence that the German business community
has in the South African health sector. This relationship looks back
on a healthy, longstanding trade relationship.

"Germany is the biggest foreign investor in South Africa within the
European Union and is responsible for creating 90,000 direct jobs and
another 90,000 indirect jobs", said Mr Matthias Boddenberg, Chief
Executive Officer of the Southern African-German Chamber of Commerce
and Industry. "That makes Germany a very important partner for South
Africa. The good infrastructure, the political stability and the
well-functioning legal system makes South Africa a good destination
for investments in the African continent."

Scott Farrell, Chief Financial Officer of B. Braun Medical, adds: "We
are grateful for the support from the various public authorities we
engaged with during this complex transaction. Following our corporate
claim "Sharing Expertise", we are fully committed to further
developing both the skills of our employees and a stronger supplier
network of BBBEE partners."

B. Braun is one of the world's leading manufacturers of medical
devices and pharmaceutical products and services. With over 56,000
employees in 64 countries, B. Braun develops high quality products,
systems and services for users around the world. In 2015, the Group
generated sales of approximately EUR6.1 billion.

ORIGINAL APA-OTS TEXT - THE INFORMATION CONTAINED IN THIS PRESS RELEASE IS SUBJECT TO THE EXCLUSIVE RESPONSIBILITY OF THE ISSUER | EUN

print